vatinoxan (Zenalpha)
Jump to navigation
Jump to search
Indications
- in combination with medetomidine as a sedative & analgesic in dogs, during clinical examination & procedures
Mechanism of action
- alpha-2 adrenergic receptor antagonist
- vatinoxan reduces negative cardiovascular effects of medetomidine
More general terms
References
- ↑ FDA approves new combination injection for sedation and pain relief in dogs. https://www.dvm360.com/view/fda-approves-new-combination-injection-for-sedation-and-pain-relief-in-dogs